Intervention

Routine clinical practice

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown2

Clinical trials

2 shown

Progression of Disease in Patients Newly Diagnosed With Glaucoma and Glaucoma Suspects Participating in the GATE StudyNCT03394521 · 2015-10-01

COMPLETED

An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.NCT02590562 · 2013-12-31

COMPLETED

Common conditions

Glaucoma1 Rheumatoid Arthritis1

Leading sponsors

Hoffmann-La Roche1 University of Aberdeen1

Trial status mix

COMPLETED2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.